Onkologie, Hämatologie - Daten und Informationen

Literatur zu Kapitel 3.8: Klinische Formen des Melanoms

Autor/en: R. Dummer, M. Beyeler
Letzte Änderung: 01.12.2006
  • Adler MJ, White CR Jr.
    Amelanotic malignant melanoma.
    Semin Cutan Med Surg 1997;16:122-130.

  • Barnetson RS, Halliday GM.
    Regression in skin tumours: a common phenomenon.
    Australas J Dermatol 1997;38 Suppl 1:63-65.

  • Binder M et al.
    Epiluminescence microscopy of small pigmented skin lesions: short-term formal training improves the diagnostic performance of dermatologists.
    J Am Acad Dermatol 1997;36:197-202.

  • Blessing K, Evans AT, al-Nafussi A.
    Verrucous naevoid and keratotic malignant melanoma: a clinico-pathological study of 20 cases.
    Histopathology 1993;23:453-458.

  • Dummer R et al.
    Melanozytäre Nävi und kutanes Melanom.
    Schweiz Med Forum 2002;10:224-230.

  • Garbe C et al.
    Associated factors in the prevalence of more than 50 common melanocytic nevi, atypical melanocytic nevi, and actinic lentigines: multicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society.
    J Invest Dermatol 1994;102:700-705.

  • Garbe C et al.
    The Malignant Melanoma Central Register of the German Society of Dermatology 1983-1993. Epidemiologic developments and current therapeutic management of malignant melanoma of the skin.
    Hautarzt 1995;46:683-692.

  • Gibson LE, Goellner JR
    Amelanotic melanoma: cases studied by Fontana stain, S-100 immunostain, and ultrastructural examination.
    Mayo Clin Proc 1988;63:777-782.

  • Helmke BM, Otto HF.
    Anorectal melanoma. A rare and highly malignant tumor entity of the anal canal.
    Pathologe 2004;25:171-177.

  • Hofbauer GF et al.
    Tyrosinase immunoreactivity in formalin-fixed, paraffin-embedded primary and metastatic melanoma: frequency and distribution.
    J Cutan Pathol 1998;25:204-209.

  • Hurst EA, Harbour JW, Cornelius LA.
    Ocular melanoma: a review and the relationship to cutaneous melanoma.
    Arch Dermatol 2003;139:1067-1073.

  • Inskip PD, Devesa SS, Fraumeni JF Jr.
    Trends in the incidence of ocular melanoma in the United States, 1974-1998.
    Cancer Causes Control 2003;14:251-257.

  • Koch SE, Lange JR.
    Amelanotic melanoma: the great masquerader.
    J Am Acad Dermatol 2000;42:731-734.

  • Kuehnl-Petzoldt C, Berger H, Wiebelt H.
    Verrucous-keratotic variations of malignant melanoma: a clinicopathological study.
    Am J Dermatopathol 1982;4:403-410.

  • Prasad ML et al.
    Primary mucosal melanoma of the head and neck: a proposal for microstaging localized, Stage I (lymph node-negative) tumors.
    Cancer 2004;100:1657-1664.

  • Schuchter L et al.
    A prognostic model for predicting 10-year survival in patients with primary melanoma. The Pigmented Lesion Group.
    Ann Intern Med 1996;125:369-375.

  • Steiner A et al.
    Verrucous malignant melanoma.
    Arch Dermatol 1988;124:1534-1537.

Bei ONKODIN publiziert in Kooperation mit "Deutscher Ärzte-Verlag"; Publikation als Buch: Deutscher Ärzte-Verlag  Deutscher Ärzte-Verlag
Aktuelle Berichte vom 58th
ASH Annual Meeting 2016,
San Diego, Kalifornien, USA [Mehr]
2016 ASCO Annual Meeting - aktuelle Berichte. Dieser Service wird gefördert durch: